Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $11.60 $17.03 Friday, 10th May 2024 ENTA stock ended at $12.65. This is 2.17% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 5.56% from a day low at $12.60 to a day high of $13.30.
90 days $11.60 $17.80
52 weeks $8.08 $28.25

Historical Enanta Pharmaceuticals prices

Date Open High Low Close Volume
Oct 21, 2016 $24.67 $24.90 $24.20 $24.60 84 100
Oct 20, 2016 $24.38 $24.78 $24.15 $24.70 89 900
Oct 19, 2016 $24.47 $24.92 $24.01 $24.36 166 400
Oct 18, 2016 $24.37 $24.48 $24.02 $24.41 222 400
Oct 17, 2016 $24.05 $24.39 $23.72 $24.09 129 600
Oct 14, 2016 $24.79 $24.95 $23.97 $24.11 124 500
Oct 13, 2016 $24.62 $26.50 $24.32 $24.64 154 900
Oct 12, 2016 $25.65 $26.09 $24.84 $24.86 173 700
Oct 11, 2016 $25.77 $26.18 $25.55 $25.74 144 400
Oct 10, 2016 $25.98 $26.35 $25.82 $25.95 132 600
Oct 07, 2016 $26.06 $26.17 $25.70 $25.80 94 300
Oct 06, 2016 $26.17 $26.17 $25.61 $25.96 147 900
Oct 05, 2016 $26.47 $26.70 $26.19 $26.33 125 000
Oct 04, 2016 $26.52 $26.74 $25.95 $26.47 257 100
Oct 03, 2016 $26.60 $26.60 $25.56 $26.57 253 400
Sep 30, 2016 $25.82 $26.87 $25.71 $26.61 217 200
Sep 29, 2016 $26.39 $26.50 $25.60 $25.70 182 200
Sep 28, 2016 $26.49 $26.71 $25.99 $26.46 267 800
Sep 27, 2016 $26.20 $26.51 $25.86 $26.44 192 600
Sep 26, 2016 $26.30 $26.35 $26.02 $26.15 154 000
Sep 23, 2016 $26.82 $26.85 $26.32 $26.39 157 000
Sep 22, 2016 $26.97 $26.97 $26.29 $26.60 309 700
Sep 21, 2016 $26.76 $27.06 $26.26 $26.81 345 600
Sep 20, 2016 $26.00 $27.46 $26.00 $26.75 509 700
Sep 19, 2016 $24.89 $25.70 $24.89 $25.65 338 500
Click to get the best stock tips daily for free!

About Enanta Pharmaceuticals

Enanta Pharmaceuticals Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro... ENTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT